Results

Magenta Therapeutics Inc.

05/12/2021 | Press release | Distributed by Public on 05/12/2021 08:06

Magenta Therapeutics Announces Positive Preliminary Results from Phase 2 Clinical Trial of MGTA-145 in Multiple Myeloma and Provides an Update on its Anticipated Clinical Study[...]